Clinical Trial

Wearable ECG for AF Screening and Stroke Risk Assessment

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the application of wearable ECG garments in atrial fibrillation (AF) screening and stroke risk assessment. Using a prospective, multicenter, observational design, the study will recruit high-risk stroke patients aged 40 and above to undergo 24-hour continuous ECG monitoring with wearable ECG garments. The study will assess the detection rate of AF and explore the correlation between heart rate variability (HRV) parameters and stroke risk. Additionally, the study will analyze the association between P-wave indices and AF, and evaluate the acceptability of the device among patients and healthcare providers. The primary goal is to validate the accuracy of wearable ECG garments in AF detection and explore their predictive value for stroke risk in high-risk populations.
Trial Details
NCT Number NCT06907264
Lead Sponsor Beijing Tsinghua Chang Gung Hospital
Collaborators: Beijing Pinggu District Hospital
Conditions Atrial Fibrillation, Stroke
Enrollment 243 participants
Start Date 2025-04-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-02